COMMUNIQUÉS West-GlobeNewswire

Valneva renouvelle son contrat de placement (Sales Agreement) dans le cadre de son programme « At-the-Market (ATM) » existant
26/03/2025
Saint-Herblain (France), 26 mars 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), (« Valneva » ou la « Société »), société spécialisée dans les vaccins, annonce aujourd’hui qu’elle a déposé auprès de la U.S. [...]
GUERBET : Résultats annuels 2024.
26/03/2025
Résultats annuels 2024 Activité très dynamique Chiffre d’affaires annuel : 841,1 M€, affichant une progression de 9,0% à taux de change constant (TCC) 1 et périmètre comparable 2 Une dynamique soutenue dans la zone [...]
GUERBET : 2024 full-year results.
26/03/2025
2024 full-year results Very strong business momentum Full-year revenue: €841.1 million, up 9.0% at constant exchange rates (CER) 1 and on a like-for-like basis 2 Strong momentum in the Americas (+20.5% at CER and like- [...]
Trading by management and close relations of management
26/03/2025
Please read the full announcement in PDF Attachment 2025_14_Trading_By_Management
RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) demonstrates significant overall survival benefit in patients with EGFR-mutated advanced non-small cell lung cancer versus osimertinib
26/03/2025
Median overall survival not yet reached with a projected improvement of more than one year versus osimertinib* 1 BEERSE, BELGIUM, March 26, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & [...]
PrimeBiome Reviews - Is it Worth Buying? Prime Biome Gummies Ingredients, Side Effects, and Investigative Report
26/03/2025
ST. PETERSBURG, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- PrimeBioMe is a natural dietary supplement designed to support gut health, improve digestion, and enhance skin appearance. It is made with a blend of plant-based [...]
iTeos présentera les données précliniques d’EOS-215, un anticorps anti-TREM2 supposé meilleur de sa catégorie, et d’un nouvel inhibiteur de PTPN1/2 lors de l’édition 2025 du congrès annuel de l’American Association for Cancer Research
26/03/2025
WATERTOWN, Massachusetts et GOSSELIES, Belgique, 26 mars 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq : ITOS), une société biopharmaceutique au stade clinique pionnière dans la découverte et le [...]
OmegaX Health ($OmegaX) Expands to Binance Smart Chain – The Future of AI Healthcare on Blockchain
26/03/2025
ELLWANGEN, Germany, March 26, 2025 (GLOBE NEWSWIRE) -- OmegaX Health ($OmegaX) , a groundbreaking AI-powered healthcare ecosystem, is set to redefine the future of medicine by combining artificial intelligence and [...]
Stryker announces intention to nominate Manny Maceda to board of directors
26/03/2025
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of [...]
Ivy En Rose Partners with Junior League of San Francisco for Exclusive Community Event on May 8, 2025
26/03/2025
SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- Ivy En Rose , San Francisco’s premier elite MedSpa, is proud to announce an exciting partnership with the Junior League of San Francisco for an exclusive community event [...]
FDA Recognizes Newly Revised AAMI Sterilization, Ethylene Oxide Guidance
26/03/2025
New versions of AAMI ST58, ST24, and TIR17 included in Recognized Consensus Standards database Arlington, VA, March 26, 2025 (GLOBE NEWSWIRE) -- AAMI is pleased to announce that the FDA has amended its database of [...]
Best SARMs For Bulking, Cutting, Muscle Growth, Fat Loss Where to buy SARMs, Alternative Stack For Sale - CrazyBulk
26/03/2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- SARMs for Bulking If you want to build muscle faster than usual, SARMs for bulking can help. Using a SARMs stack (a combination of supplements) gives better results than [...]
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
26/03/2025
Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]
Dr. Lyudmila Sarder Receives Prestigious U.S. Congressional Award for Women’s History Month
26/03/2025
"Trailblazing Physician and Advocate Receives U.S. Congressional Award for Advancing Healthcare Access and Community Service Across Central Florida and Beyond" WASHINGTON, March 26, 2025 (GLOBE NEWSWIRE) -- Dr. Lyudmila [...]
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
26/03/2025
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced [...]
Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025
26/03/2025
CORAL GABLES, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, or “the Company”), a clinical-stage biotechnology company committed to advancing innovative breakthrough [...]
Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider
26/03/2025
Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published by Zelluna ASA (the "Company") published on 26 March 2025 regarding the resolution by the Company's board of directors to carry out a [...]
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
26/03/2025
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage [...]
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
26/03/2025
AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatment REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics , a clinical-stage biopharmaceutical company [...]

Pages